Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics

Código QR

Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics

Usman Adam, Nusrat Husain, Peter M Haddad, Tariq Munshi, Fauzia Tariq, Farooq Naeem, Imran B ChaudhryBackground: Tardive dyskinesia (TD) is a side effect of antipsychotic treatment that often only appears after months or years of treatment. A systematic review of randomized controlled trials lastin...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Adam UU, Husain N, Haddad PM, Munshi T, Tariq F, Naeem F, Chaudhry IB
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/46735a3513ae4310b590bface71137c9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Tardive Dyskinesia in Older Persons Taking Antipsychotics
por: Citrome L, et al.
Publicado: (2021)

The relationship between childhood trauma and adult psychosis in a UK Early Intervention Service: results of a retrospective case note study
por: Reeder FD, et al.
Publicado: (2017)

Treatment of neurolept-induced tardive dyskinesia
por: Jankelowitz SK
Publicado: (2013)

Overcoming barriers to effective management of tardive dyskinesia
por: Caroff SN
Publicado: (2019)

Scopolamine alleviates involuntary lingual movements: tardive dyskinesia or dystonia?
por: Hu JB, et al.
Publicado: (2017)

Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel Recommendations
por: Jackson R, et al.
Publicado: (2021)

The effects of electroconvulsive therapy on tardive dystonia or dyskinesia induced by psychotropic medication: a retrospective study
por: Yasui-Furukori N, et al.
Publicado: (2014)

No association between cortical dopamine D2 receptor availability and cognition in antipsychotic-naive first-episode psychosis
por: Maria Lee, et al.
Publicado: (2021)

Characterization of antipsychotic medications, amino acid signatures, and platelet-activating factor in first-episode psychosis
por: Bracha Erlanger Avigdor, et al.
Publicado: (2021)

Markers of neurodevelopmental impairments in early-onset psychosis
por: Petruzzelli MG, et al.
Publicado: (2015)

Drug and alcohol misuse in first episode psychosis: An observational study
por: Kathleen Crebbin, et al.
Publicado: (2008)

Odor perception and hedonics in chronic schizophrenia and in first episode psychosis
por: Urban-Kowalczyk M, et al.
Publicado: (2019)

Psychotropic Medications-Induced Tardive Dyskinesia and Associated Factors Among Patients with Mental Illness in Ethiopia
por: Kumsa A, et al.
Publicado: (2020)

Efficacy of second-generation antipsychotics in patients at ultra-high risk and those with first- episode or multi-episode schizophrenia
por: Washida K, et al.
Publicado: (2013)

Surface area in the insula was associated with 28-month functional outcome in first-episode psychosis
por: Shinsuke Koike, et al.
Publicado: (2021)

Structure and stability of symptoms in first episode psychosis: a longitudinal network approach
por: Siân Lowri Griffiths, et al.
Publicado: (2021)

Screening for pathogenic neuronal autoantibodies in serum and CSF of patients with first-episode psychosis
por: Jakob Theorell, et al.
Publicado: (2021)

Use of second-generation antipsychotics in the acute inpatient management of schizophrenia in the Middle East
por: Alkhadhari S, et al.
Publicado: (2015)

Atypical antipsychotics for Parkinson’s disease psychosis: a systematic review and meta-analysis
por: Zhang H, et al.
Publicado: (2019)

The Implementation and Review of Cognitive Remediation Training for First Episode Psychosis in Singapore
por: Nigel Ian Ming Chong, et al.
Publicado: (2021)

Intrinsic cerebellar functional connectivity of social cognition and theory of mind in first-episode psychosis patients
por: Soo Hwan Park, et al.
Publicado: (2021)

The effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: a preliminary study
por: Gro&scaron;ić V, et al.
Publicado: (2014)

Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers
por: Ishioka M, et al.
Publicado: (2015)

Gender Differences in the First-Year Antipsychotic Treatment for Chinese First-Episode Schizophrenia
por: Pu C, et al.
Publicado: (2020)

Angiotensin II type 1/adenosine A 2A receptor oligomers: a novel target for tardive dyskinesia
por: Paulo A. de Oliveira, et al.
Publicado: (2017)

Decreased Gray Matter Volume of Cuneus and Lingual Gyrus in Schizophrenia Patients with Tardive Dyskinesia is Associated with Abnormal Involuntary Movement
por: Ting Yu, et al.
Publicado: (2018)

Verbal memory improvement in first-episode psychosis APOE-ε4 carriers: a pleiotropic effect?
por: Vila-Rodriguez F, et al.
Publicado: (2017)

Conceptual disorganization and redistribution of resting-state cortical hubs in untreated first-episode psychosis: A 7T study
por: Avyarthana Dey, et al.
Publicado: (2021)

Impairment of novelty-related theta oscillations and P3a in never medicated first-episode psychosis patients
por: Rodolfo Solís-Vivanco, et al.
Publicado: (2021)

Real-World Effectiveness and Safety of Antipsychotics in Individuals at Clinical High-Risk for Psychosis: Study Protocol for a Prospective Observational Study (ShangHai at Risk for Psychosis-Phase 2)
por: Wu G, et al.
Publicado: (2019)

Post-stroke dyskinesias
por: Nakawah MO, et al.
Publicado: (2016)

Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review
por: Karson C, et al.
Publicado: (2016)

Clinical Validity of Subjective Clinical Prognosis in First Episode Psychosis Schizophrenia Patients: An Analysis of Data from the European First Episode Schizophrenia Trial (EUFEST) Study
por: Matei VP, et al.
Publicado: (2020)

Long-Acting Injectable Antipsychotics: A Systematic Review of Their Non-Systemic Adverse Effect Profile
por: Zolezzi M, et al.
Publicado: (2021)

Anti-NMDA receptor antibodies in patients with a first episode of schizophrenia
por: Masopust J, et al.
Publicado: (2015)

Changes in Brain Structure, Function, and Network Properties in Patients With First-Episode Schizophrenia Treated With Antipsychotics
por: Ping Yin, et al.
Publicado: (2021)

Iminodibenzyl class antipsychotics for schizophrenia: a systematic review and meta-analysis of carpipramine, clocapramine, and mosapramine
por: Kishi T, et al.
Publicado: (2014)

Plasma bilirubin levels are reduced in first-episode psychosis patients and associates to working memory and duration of untreated psychosis
por: Meneca Becklén, et al.
Publicado: (2021)

Effects of Lithium Combined with Second-Generation Antipsychotics for the Treatment of Manic Episodes in Patients with Bipolar Disorder: A Naturalistic Study in China
por: Liu Y, et al.
Publicado: (2020)

Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophrenia
por: Goto N, et al.
Publicado: (2012)